Search

Author/Creator Garkaviy, Pavlo

1. Drug-induced myocardial dysfunction – recommendations for assessment in clinical and pre-clinical studies. Issue 3 (3rd March 2020)

Authors:
Ebrahimi, Ahmad; Raichlen, Joel S; Pointon, Amy; Gottfridsson, Christer; Munley, Jiefen; Hockings, Paul; Cartwright, James; Buss, Nicholas; Wikström, Johannes; Gan, Li-Ming; Whittaker, Andrew; Khalil, Ali; George, Richard T; Garkaviy, Pavlo; Brott, David
Journal:
Expert opinion on drug safety
Issue:
Volume 19:Issue 3(2020)
Page Start:
281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study. (15th October 2022)

Authors:
Prescott, Eva; Angerås, Oskar; Erlinge, David; Grove, Erik L.; Hedman, Marja; Jensen, Lisette O.; Pernow, John; Saraste, Antti; Åkerblom, Axel; Svedlund, Sara; Rudvik, Anna; Knöchel, Jane; Lindstedt, Eva-Lotte; Garkaviy, Pavlo; Gan, Li-Ming; Gabrielsen, Anders
Journal:
International journal of cardiology
Issue:
Volume 365(2022)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search